Related Experiment Videos

Lowering of dopamine metabolites in rat brain by harmaline

R W Fuller, S K Hemrick-Luecke, K W Perry

The Journal of Pharmacy and Pharmacology

|April 1, 1981

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Norepinephrine metabolism in the cerebellum of the purkinje cell degeneration (pcd) mutant mouse.

Neurochemistry international·2010

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.

Molecular psychiatry·2005

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Proceedings of the National Academy of Sciences of the United States of America·2001

The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus.

European journal of pharmacology·2001

Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.

Neuropharmacology·2001

The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex.

Biological psychiatry·2001

See all related articles